4//SEC Filing
Chen Hongming 4
Accession 0001104659-20-078279
CIK 0001479419other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 9:31 PM ET
Size
5.0 KB
Accession
0001104659-20-078279
Insider Transaction Report
Form 4
Chen Hongming
Chief Scientific Officer10% Owner
Transactions
- Award
Comman Stock
2020-06-25+16,000→ 102,849 total
Footnotes (2)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued employment with the Issuer, the RSUs will vest as to 50% of the shares underlying the RSUs on June 25, 2021 and the remaining 50% of the shares underlying the RSUs on June 25, 2022.
- [F2]Includes 16,000 unvested RSUs.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001710697
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 9:31 PM ET
- Size
- 5.0 KB